Cantor Fitzgerald Lowers Price Target On Curaleaf After Q2 Earnings Report, Still Among Top Picks In MSO Group

company Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) reported sales of $312.2 million in the second quarter of 2021, beating the estimate by $4.38 million.

According to the earnings report the company posted on Monday after market close, that's a 20% sequential and 166% year-over-year pop in revenue. GAAP diluted earnings per share were negative $0.01.

The Analyst

Cantor Fitzgerald's Pablo Zuanic kept an 'Overweight' rating on Curaleaf stock, lowering the price target to $24 from $26.50.

The Thesis

The analyst said Tuesday that the reported sequential organic sales growth of 18% was "above the underlying market growth of low teens in the company's markets."

According to Zuanic, sales from the company's top five states, including Florida, …

Full story available on Benzinga.com

More Cantor Fitzgerald Lowers Price Target On Curaleaf After Q2 Earnings Report, Still Among Top Picks In MSO Group